Apalutamide

Active ingredient description

Apalutamide is an orally administered, selective Androgen Receptor (AR) inhibitor that binds directly to the ligand-binding domain of the AR. Apalutamide treatment decreases tumor cell proliferation and increases apoptosis leading to potent antitumor activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
L02BB05
Apalutamide
L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BB Anti-androgens
Discover more medicines within L02BB05

Medicines

Apalutamide is the active ingredient of these drugs:

Drug
Countries
ERLEADA

Austria Brazil Canada Cyprus Finland

ERLYAND

New Zealand

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
ERLEADA Film-coated tablet
Summary of Product Characteristics (SPC)

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

4T36H88UA7 - APALUTAMIDE

SNOMED-CT

766972001 - Apalutamide (substance)

Next: Usage